skip to Main Content

Three Quick Facts: MJ Gleeson, Serco and AstraZeneca


Three things you need to know in the financial markets this morning from investment writer, Tony Cross

MJ Gleeson

Media speculation over the weekend has forced MJ Gleeson to publish a statement this morning. The company is exploring the idea of divesting its strategic land banking business. Such a move would bring handsome returns for investors as the division is said to be worth £130 million. Arguably such a move would also provide a layer of protection against political risk as these operations do have a degree of contention about them, especially given the continued uptrend in housing prices.


Serco have signed a contract which will see its involvement with Dubai’s metro system extended for a further two years. The deal, worth an estimated £140 million, should be welcomed by investors.


AstraZeneca has received Break Through Designation on another new drug – the ninth since 2014 – from the US FDA. This enables faster approvals for clinical trials of new medication, although investors – and patients – will arguably be rather more focused on how the drug progresses through the trial phases, rather than this news alone.

Like this article? Sign up to our free newsletter.

This article does not constitute investment advice. Do your own research or consult a professional advisor.

The Armchair Trader's 'How to' Guides

Read our latest in-depth company reports

Detailed reviews of selected companies and investment trusts.

Listen to our latest podcast episodes

Thanks to our Partners

Our partners are established, regulated businesses and we are grateful for their support.

FP Markets
CME Group
Back To Top